ASP1002

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP1002, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP1002 in Adults for Treatment of Solid Tumors [Phase 1]